Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.
نویسندگان
چکیده
macrocyclic structure as postulated by the authors; nevertheless this hypothesis must not be rejected and should always be checked. Thus, all mild to severe adverse hypersensitivity reactions should be accurately documented with most of the available gadolinium in order to determine cross reactivities. This is all the more important since challenge with another gadolinium agent giving negative skin tests could be performed safely, therefore allowing these patients further MRI explorations if necessary. This documentation should now be as rigorous as for hypersensitivity reactions associated with iodinated contrast media (4). Moreover these gadolinium reactions may be IgE-mediated more often than with iodinated contrast media because gadolinium would lead to lesser nonspecific histamine release caused by hyperosmolarity.
منابع مشابه
Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody.
Allergic bronchopulmonary aspergillosis (ABPA) can cause severe worsening of the respiratory condition in patients with cystic fibrosis. Treatment can result in steroid dependency and serious adverse events. A dramatic and rapid improvement of respiratory symptoms and lung function after a single dose of anti-IgE antibody (omalizumab) in a 12-year-old girl with cystic fibrosis and ABPA is descr...
متن کاملSteroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is a common serious hypersensitivity reaction to airway colonization with Aspergillus in patients with asthma or cystic fibrosis. While steroids are effective in controlling the respiratory symptoms of ABPA, they have many side effects that make them undesirable for long term use. Antifungals have been used to reduce dependency on system...
متن کاملAllergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
BACKGROUND Current therapy for allergic bronchopulmonary aspergillosis (ABPA) uses oral corticosteroids, exposing patients to the adverse effects of these agents. There are reports of the steroid-sparing effect of anti-IgE therapy with omalizumab for ABPA in patients with cystic fibrosis (CF), but there is little information on its efficacy against ABPA in patients with bronchial asthma without...
متن کاملAnti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Allergic bronchopulmonary aspergillosis (ABPA) occurs in 7-9% of patients with cystic fibrosis (CF) and causes a worsening of lung function and respiratory symptoms. Standard treatment of ABPA consists of oral steroids; however, higher corticosteroid therapy associated to antifungal agent (itraconazole) long-term treatments are often required to reduce respiratory exacerbations and to prevent p...
متن کاملA case report of ABPA, cystic fibrosis and asthma treated with omalizumab
Introduction In Canada the use of Omalizumab is restricted to patients with moderate to severe allergic asthma. However there are some cases reports showing its effectiveness in other conditions like chronic urticaria, ABPA and patients with nasal polyps and asthma. Although there are also reports of using omalizumab in patients with cystic fibrosis and ABPA, there are not controlled trials con...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Allergy
دوره 65 1 شماره
صفحات -
تاریخ انتشار 2010